Guo et al.13 found that TRIP6 is overexpressed in CRC samples, and TRIP6 can promote CRC metastasis by disrupting tight junctions and activating Akt signaling through direct interaction with PARD3. Here, AKT1 is linked to colorectal carcinoma.